RWANDA BIOMEDICAL CENTRE
🇷🇼Rwanda
Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (66.7%)Phase 2
1 (33.3%)Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwanda
Phase 4
Not yet recruiting
- Conditions
- Cervical Cancer
- First Posted Date
- 2024-08-05
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Rwanda Biomedical Centre
- Target Recruit Count
- 100000
- Registration Number
- NCT06536855
Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis
- First Posted Date
- 2022-09-26
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Rwanda Biomedical Centre
- Target Recruit Count
- 20
- Registration Number
- NCT05555303
- Locations
- 🇷🇼
Kabutare hospital, Kabutare, Rwanda
News
Sabin Launches U.S. Phase 2 Trial for Marburg Vaccine Amid Rising Global Outbreaks
The Sabin Vaccine Institute has initiated a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, building on ongoing trials in Kenya and Uganda.
Rwanda Battles Rift Valley Fever Outbreak, Seeks Rapid Diagnostics
Rwanda is intensifying measures against a Rift Valley Fever (RVF) outbreak following a recent resurgence near the Tanzanian border, raising concerns about potential human transmission.